Zobrazeno 1 - 10
of 527
pro vyhledávání: '"Kenneth A. Bauer"'
Publikováno v:
Research and Practice in Thrombosis and Haemostasis, Vol 6, Iss 1, Pp n/a-n/a (2022)
Abstract Background Aspirin is commonly used as the only pharmacologic agent for prevention of venous thromboembolism (VTE) after joint replacement surgery in the United States. Despite this, prospective studies investigating VTE events after aspirin
Externí odkaz:
https://doaj.org/article/df781562758448689eef4eba84306980
Autor:
Irene D. Bezemer, Andre R. Arellano, Carmen H. Tong, Charles M. Rowland, Helen A. Ireland, Kenneth A. Bauer, Joseph Catanese, Pieter H. Reitsma, Carine J.M. Doggen, James J. Devlin, Frits R. Rosendaal, Lance A. Bare
Publikováno v:
Haematologica, Vol 94, Iss 5 (2009)
Background We recently reported the association between the Malmö sequence variant in F9 (rs6048) and deep vein thrombosis.Design and Methods We aimed to study whether the association between F9 Malmö and deep vein thrombosis is explained by linkag
Externí odkaz:
https://doaj.org/article/a9c1015a5caa4c47ab36726daa535a8f
Autor:
Bruce Furie, Barbara C. Furie, Kenneth A. Bauer, Romaric Lacroix, Donna Neuberg, Howard A. Liebman, Jeffrey I. Zwicker
Supplementary Data from Tumor-Derived Tissue FactorBearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5aad7e6012ac0ad4c3e2cd36979c9984
https://doi.org/10.1158/1078-0432.22440705
https://doi.org/10.1158/1078-0432.22440705
Autor:
Bruce Furie, Barbara C. Furie, Kenneth A. Bauer, Romaric Lacroix, Donna Neuberg, Howard A. Liebman, Jeffrey I. Zwicker
Purpose: Despite the strong association between malignant disease and thromboembolic disorders, the molecular and cellular basis of this relationship remains uncertain. We evaluated the hypothesis that tumor-derived tissue factorbearing microparticle
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67c634474010be5e2c11d7ef2fe4af70
https://doi.org/10.1158/1078-0432.c.6518001
https://doi.org/10.1158/1078-0432.c.6518001
Publikováno v:
American Journal of Health-System Pharmacy. 79:1323-1329
PurposeTo manage factor Xa (FXa) inhibitor–associated bleeding, andexanet alfa or 4-factor prothrombin concentrate (4F-PCC) has been used to restore hemostasis. However, literature on the outcomes for patients who received both andexanet alfa and 4
Publikováno v:
Journal of Algorithms & Computational Technology, Vol 12 (2018)
Firewalls, especially at large organizations, process high velocity internet traffic and flag suspicious events and activities. Flagged events can be benign, such as misconfigured routers, or malignant, such as a hacker trying to gain access to a spe
Externí odkaz:
https://doaj.org/article/e3b22c9241d1496ea9ac4354843bafd9
Publikováno v:
Journal of Algorithms & Computational Technology, Vol 12 (2018)
In classification applications, the goal of fusion techniques is to exploit complementary approaches and merge the information provided by these methods to provide a solution superior than any single method. Associated with choosing a methodology to
Externí odkaz:
https://doaj.org/article/5e21f18cc3b6490d907ca8191dd52293
Autor:
Sai-Hong Ignatius Ou, Yanfei Gao, Viola W. Zhu, Kenneth A. Bauer, Joseph J. Zhao, Nicholas Syn, Shannon S. Zhang, Misako Nagasaka
Publikováno v:
Lung Cancer. 157:147-155
INTRODUCTION Increased thromboembolism (TE) has been reported in ALK+ and ROS1+ non-small cell lung cancer (NSCLC). MATERIALS AND METHODS Odds ratios (OR) and hazard ratios (HR) of TE were calculated from meta-analysis and time-to-event analysis resp
Autor:
Kenneth A. Bauer, Thita Chiasakul
Publikováno v:
Hematology Am Soc Hematol Educ Program
Although anticoagulation remains the mainstay of treatment of acute venous thromboembolism (VTE), the use of thrombolytic agents or thrombectomy is required to immediately restore blood flow to thrombosed vessels. Nevertheless, systemic thrombolysis
Autor:
Gregg W. Stone, Nandini Nair, Sumit Mohan, Neha Ahluwalia, Aakriti Gupta, Mahesh V. Madhavan, Mitchell S.V. Elkind, Mathew S. Maurer, Anna S. Nordvig, Elaine Wan, Harlan M. Krumholz, John P. Bilezikian, Domenico Accili, Martin B. Leon, Joan M. Bathon, Tejasav S. Sehrawat, Behnood Bikdeli, Allan Schwartz, Donald W. Landry, John C. Ausiello, Shiwani Mahajan, Kenneth A. Bauer, David D. Ho, Ajay J. Kirtane, Sahil A. Parikh, Daniel E. Freedberg, Mandeep R. Mehra, Nir Uriel, Kartik Sehgal
Publikováno v:
Nature Medicine
Although COVID-19 is most well known for causing substantial respiratory pathology, it can also result in several extrapulmonary manifestations. These conditions include thrombotic complications, myocardial dysfunction and arrhythmia, acute coronary